Exane Derivatives ALEXION PHARM. Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 30, 2021
SELL
N/A
-1,472 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
N/A
306 Added 26.24%
1,472 $0
Q3 2020

Oct 06, 2020
SELL
N/A
-66 Reduced 5.36%
1,166 $0
Q2 2020

Jul 10, 2020
SELL
N/A
-4,928 Reduced 80.0%
1,232 $0
Q1 2020

Apr 17, 2020
BUY
N/A
4,961 Added 413.76%
6,160 $0
Q4 2019

Jan 22, 2020
SELL
N/A
-1,003 Reduced 45.55%
1,199 $0
Q3 2019

Oct 15, 2019
BUY
N/A
1,300 Added 144.12%
2,202 $0
Q2 2019

Jul 12, 2019
BUY
N/A
902 New
902 $0
Q1 2019

Apr 24, 2019
SELL
N/A
-24 Closed
0 $0
Q3 2018

Oct 24, 2018
SELL
N/A
-980 Reduced 97.61%
24 $0
Q2 2018

Oct 24, 2018
BUY
N/A
1,004 New
1,004 $0
Q2 2018

Jul 19, 2018
SELL
N/A
-1,155 Closed
0 $0
Q1 2018

Apr 30, 2018
BUY
N/A
736 Added 175.66%
1,155 $0
Q4 2017

Jan 29, 2018
BUY
N/A
137 Added 48.58%
419 $0
Q3 2017

Oct 18, 2017
BUY
N/A
282
282 $0
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email